Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur Unit

Sanofi, Regeneron Dupixent sBLA accepted for USFDA review for chronic spontaneous urticaria

Written By Ruchika Sharma17 Nov 2024 4:15 PM IST

Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the...

Sanofis Thyrotropin Alfa Label Update: CDSCO Panel Recommends New Prescription Warning, Limits Sale to Specialists Only

Sarclisa recommended for EU approval by CHMP to treat transplant-ineligible newly diagnosed multiple myeloma: Sanofi

Written By Ruchika Sharma17 Nov 2024 4:00 PM IST

Paris: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) has adopted a...

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

BioNTech to acquire clinical-stage biotechnology company Biotheus

Written By Ruchika Sharma17 Nov 2024 2:00 PM IST

Germany: BioNTech SE and Biotheus have announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage...

Over 10 countries looking to imbibe India's generic pharmacy model: Report

Written By Ruchika Sharma17 Nov 2024 11:45 AM IST

New Delhi: In an effort to provide affordable medicines to the public, more than 10 countries are looking to imbibe India's generic pharmacy model, as...

GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and older

GSK, Vesalius Therapeutics collaborate for novel treatments for Parkinson's disease

Written By Ruchika Sharma16 Nov 2024 12:35 PM IST

Cambridge: Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, has...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

JnJ MedTech gets IDE approval for OTTAVA Robotic Surgical System

Written By Ruchika Sharma15 Nov 2024 5:05 PM IST

New Brunswick: Johnson & Johnson MedTech has announced that the U.S. Food & Drug Administration (USFDA) has approved the OTTAVA...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

AstraZeneca, Daiichi Sankyo submits Datopotamab deruxtecan new BLA for accelerated approval in US for lung cancer

Written By Ruchika Sharma14 Nov 2024 3:15 PM IST

AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US for datopotamab deruxtecan...

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK Ojjaara approved in Canada for treatment of myelofibrosis in adults who have moderate to severe anemia

Written By Ruchika Sharma14 Nov 2024 1:15 PM IST

Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or...

Shukra Pharma Signs MoU With US Firm for AI Surgical Robotics in India

Ginkgo Bioworks advances collaboration with Merck to improve Biologics manufacturing

Written By Ruchika Sharma14 Nov 2024 12:33 PM IST

Boston: Ginkgo Bioworks has announced the completion of the first milestone of a previously announced partnership with Merck, known as MSD outside of...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Cipla gets 8 USFDA observations for Virgonagar facility

Written By Ruchika Sharma14 Nov 2024 12:01 PM IST

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the Company's...

Shanghai Pharma Vice President expresses hope for increased investment from Indian pharma cos in China

Written By Ruchika Sharma13 Nov 2024 2:25 PM IST

Shanghai: Li Dongming, Vice President of Shanghai Pharmaceuticals, expressed hope on Tuesday for more investment from Indian pharmaceutical...

Traveres Filspari Becomes First USFDA-Approved Drug for FSGS Treatment

USFDA accepts Shilpa Medicare CDMO partner Unicycive NDA for Oxylanthanum Carbonate

Written By Ruchika Sharma13 Nov 2024 12:13 PM IST

Karnataka: Shilpa Medicare CDMO partner Unicycive Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (USFDA) has...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok